Characterization of Ventricular and Atrial Cardiomyocyte Subtypes from Human-Induced Pluripotent Stem Cells

Area of Science:

• Cardiovascular Biology and Regenerative Medicine
• Stem Cell Biology and Therapeutics

Background:

• Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) hold promise for regenerative medicine and drug discovery in heart failure.
• hiPSC-CMs are a heterogeneous population, primarily comprising ventricular cardiomyocytes (VCMs) with contributions from atrial cardiomyocytes (ACMs) and pacemaker cells.
• Efficient differentiation and characterization of specific cardiomyocyte subtypes are crucial for their therapeutic and research applications.

Purpose of the Study:

• To develop and validate a method for enriching differentiation of VCMs and ACMs from hiPSC-CMs.
• To characterize the molecular and electrophysiological properties of enriched VCM and ACM subtypes.

Main Methods:

• Utilized a novel method to enrich for VCM and ACM differentiation from hiPSC-CMs.
• Performed gene expression analysis using quantitative reverse transcription polymerase chain reaction (qRT-PCR) to identify subtype-specific markers.
• Assessed electrophysiological properties of differentiated subtypes using the patch-clamp technique.

Main Results:

• Enriched VCMs and ACMs demonstrated high expression of their respective marker genes.
• Both VCM and ACM subtypes exhibited distinct and specific action potential properties.
• The developed method allows for the isolation and characterization of distinct cardiomyocyte subtypes.

Conclusions:

• The described method successfully enriches for VCM and ACM differentiation from hiPSC-CMs.
• Characterization confirms distinct gene expression profiles and electrophysiological behaviors of VCMs and ACMs.
• This advancement facilitates the study and application of specific cardiomyocyte subtypes in cardiac research and therapy.